These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7083598)

  • 41. Effect of hyperthyroidism of short duration on cardiac sensitivity to beta-adrenergic stimulation.
    Martin WH; Spina RJ; Korte E
    J Am Coll Cardiol; 1992 May; 19(6):1185-91. PubMed ID: 1314272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Propranolol dynamics in thyrotoxicosis.
    Feely J; Stevenson IH; Crooks J
    Clin Pharmacol Ther; 1980 Jul; 28(1):40-4. PubMed ID: 7389252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Contribution of the renin-angiotensin system to blood pressure variability in hyperthyroid rats].
    Basset A; Blanc J; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):905-10. PubMed ID: 10989728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antihypertensive effect and degree of beta-adrenoceptor blockade after short-term and semi-chronic propranolol therapy.
    Leenen FH; Boer P; Dorhout Mees EJ
    Br J Clin Pharmacol; 1984 Jun; 17(6):745-52. PubMed ID: 6146329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced gluconeogenic capacity from glycerol in hyperthyroid man: evidence in favour of a beta-adrenergic mechanism.
    McCulloch AJ; Steele NR; Kendall-Taylor P; Baylis PH; Alberti KG
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):399-407. PubMed ID: 6096044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative pharmacodynamics and plasma levels of beta-adrenoceptor blocking drugs.
    Gugler R; Krist R; Raczinski H; Höffgen K; Bodem G
    Br J Clin Pharmacol; 1980 Oct; 10(4):337-43. PubMed ID: 6108780
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of propranolol on circulating thyroid hormone measurements in thyrotoxic and euthyroid subjects.
    Franklyn JA; Wilkins MR; Wilkinson R; Ramsden DB; Sheppard MC
    Acta Endocrinol (Copenh); 1985 Mar; 108(3):351-5. PubMed ID: 3920853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circadian blood pressure and heart rate profiles in normotensive patients with mild hyperthyroidism.
    Kohno I; Iwasaki H; Okutani M; Mochizuki Y; Sano S; Satoh Y; Ishihara T; Ishii H; Ijiri H; Komori S; Tamura K
    Chronobiol Int; 1998 Jul; 15(4):337-47. PubMed ID: 9706411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on circadian heart rate.
    Fitscha P; Tiso B; Meisner W; Spitzer D
    Br J Clin Pharmacol; 1982; 13(Suppl 2):211S-215S. PubMed ID: 6125172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta-adrenoreceptor blocking drugs and thyroid hormones in hyperthyroid subjects.
    Jones MK; Birtwell J; Owens DR; Jones GR; Lewis M
    Postgrad Med J; 1981 Apr; 57(666):207-9. PubMed ID: 6117063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular response in hyperthyroidism. The influence of adrenergic-receptor blockade.
    Pietras RJ; Real MA; Poticha GS; Bronsky D; Waldstein SS
    Arch Intern Med; 1972 Mar; 129(3):426-9. PubMed ID: 4401571
    [No Abstract]   [Full Text] [Related]  

  • 53. The influence of beta-adrenoceptor blocking agents on plasma thyroxine and triiodothyronine.
    Wiersinga WM; Touber JL
    J Clin Endocrinol Metab; 1977 Aug; 45(2):293-8. PubMed ID: 885993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastrointestinal transit in hyperthyroid patients before and after propranolol treatment.
    Bozzani A; Camboni MG; Tidone L; Cesari P; Della Mussia F; Quatrini M; Ghilardi G; Ferrar L; Bianchi PA
    Am J Gastroenterol; 1985 Jul; 80(7):550-2. PubMed ID: 4014104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of adrenergic receptor blockade on the responses to isometric handgrip: studies in normal and hypertensive subjects.
    McAllister RG
    J Cardiovasc Pharmacol; 1979; 1(2):253-63. PubMed ID: 94394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adrenergic hypersensitivity after beta-blocker withdrawal.
    Ross PJ; Lewis MJ; Sheridan DJ; Henderson AH
    Br Heart J; 1981 Jun; 45(6):637-42. PubMed ID: 6114739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contribution of the autonomic nervous system to blood pressure and heart rate variability changes in early experimental hyperthyroidism.
    Safa-Tisseront V; Ponchon P; Laude D; Elghozi JL
    Eur J Pharmacol; 1998 Jul; 352(2-3):247-55. PubMed ID: 9716361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Power spectral analysis of heart rate in hyperthyroidism.
    Cacciatori V; Bellavere F; Pezzarossa A; Dellera A; Gemma ML; Thomaseth K; Castello R; Moghetti P; Muggeo M
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2828-35. PubMed ID: 8768838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood pressure and plasma noradrenaline during single high-dose beta adrenoceptor blockade.
    Maling TJ; Ferrara A; Mucklow JC; Reid JL; Hamilton CA; Dollery CT
    Eur J Clin Pharmacol; 1979 Jul; 15(6):375-9. PubMed ID: 40797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The acute hemodynamic changes of beta-adrenergic blockade in patients with thyrotoxicosis.
    Schweitzer P; Pivonka M; Zeman R; Gregorová J; Merstenová E
    Z Kreislaufforsch; 1968 Dec; 57(12):1212-20. PubMed ID: 4387873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.